Telomerase inhibitors - Oligonucleotide phosphoramidates as potential therapeutic agents

S. Gryaznov, K. Pongracz, T. Matray, R. Schultz, R. Pruzan, J. Aimi, A. Chin, C. Harley, B. Shea-Herbert, J. Shay, Y. Oshima, A. Asai, Y. Yamashita

Research output: Contribution to journalArticle

59 Scopus citations

Abstract

We have designed, synthesized, and evaluated using physical, chemical and biochemical assays various oligonucleotide N3′ → P5′ phosphoramidates, as potential telomerase inhibitors. Among the prepared compounds were 2′-deoxy, 2′-hydroxy, 2′-methoxy, 2′-ribo-fluoro, and 2′-arabino-fluoro oligonucleotide phosphoramidates, as well as novel N3′ → P5′ thio-phosphoramidates. The compounds demonstrated sequence specific and dose dependent activity with IC50 values in the sub-nM to pM concentration range.

Original languageEnglish (US)
Pages (from-to)401-410
Number of pages10
JournalNucleosides, Nucleotides and Nucleic Acids
Volume20
Issue number4-7
DOIs
StatePublished - 2001

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Genetics

Fingerprint Dive into the research topics of 'Telomerase inhibitors - Oligonucleotide phosphoramidates as potential therapeutic agents'. Together they form a unique fingerprint.

  • Cite this

    Gryaznov, S., Pongracz, K., Matray, T., Schultz, R., Pruzan, R., Aimi, J., Chin, A., Harley, C., Shea-Herbert, B., Shay, J., Oshima, Y., Asai, A., & Yamashita, Y. (2001). Telomerase inhibitors - Oligonucleotide phosphoramidates as potential therapeutic agents. Nucleosides, Nucleotides and Nucleic Acids, 20(4-7), 401-410. https://doi.org/10.1081/NCN-100002314